We detected significantly increased levels of FITC-dextran in the serum of the AIM2−/− mice at 15 days after the STZ injections, when compared to the WT mice (Figure 6A), suggesting that the intestinal barrier of the AIM2−/− mice is disrupted during T1D. This evidence concerns the gene AIM2 and type 1 diabetes mellitus.